Without committing to open science practices, we risk producing a psychedelics industry with the same efficacy and integrity as the self-help industry.
There are a number of unique issues that psychedelics present in a clinical setting that are yet to be adequately addressed.
The essays collected in this symposium represent a diversity of viewpoints about the field of psychedelic studies and its potential futures, rather than a consensus perspective. Despite differences in opinion, disciplinary vantage point, and level…
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.
There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included under this umbrella.
A rundown of the major legal questions at play in the New York Times-OpenAI lawsuit.
This #MaternalHealthAwarenessDay, insist on comprehensive Medicaid coverage for moms.
This concluding post attempts to synthesize contributions to the symposium “From Principles to Practice: Human Rights and Public Health Emergencies”
“Plan C” makes a strong case that the law has failed people with the capacity to become pregnant.
Shovel-ready actions that could be taken to support the harm reduction response to the opioid crisis.
